CHRO

Channel Therapeutics Corp

Insider trading activity for Channel Therapeutics Corp, straight from SEC Form 4 filings. Net figures below count open-market buys and sales only — grants, option exercises and tax withholding are excluded because they are compensation, not decisions to trade.

Past 3 months

-$55.9K

net selling

Bought(0 · 0 insiders): $0
Sold(6 · 3 insiders): $55.9K

Past 6 months

+$838.9K

net buying

Bought(2 · 1 insiders): $1M
Sold(17 · 5 insiders): $161.1K

Past 12 months

+$558.6K

net buying

Bought(2 · 1 insiders): $1M
Sold(21 · 5 insiders): $441.3K

Transaction history

The 74 most recent Form 4 transactions.

Open in screener →

Insider transactions, newest first: date, security, transaction type, size and a link to the filing each row came from.
Date	Insider	Role	Type	Shares	Price	Value	Δ Own	Filing
Jul 2	Pauls Matthew	Director	SSELL◷	94	$27.36	$2.6K	-0.7%	Open the original filing on SEC.gov
Jul 2	Pauls Matthew	Director	SSELL◷	692	$26.00	$18K	-4.6%	Open the original filing on SEC.gov
Jul 2	Greenleaf Peter	Director	SSELL◷	85	$27.27	$2.3K	-0.4%	Open the original filing on SEC.gov
Jul 2	Greenleaf Peter	Director	SSELL◷	712	$26.00	$18.5K	-2.9%	Open the original filing on SEC.gov
Jul 2	Friedberg Ezra M	Director	SSELL◷	24	$27.33	$656	<0.1%	Open the original filing on SEC.gov
Jul 2	Friedberg Ezra M	Director	SSELL◷	534	$26.03	$13.9K	-0.7%	Open the original filing on SEC.gov
Jun 15	Friedberg Ezra M	Director	SSELL◷	59	$27.94	$1.6K	<0.1%	Open the original filing on SEC.gov
Jun 15	Friedberg Ezra M	Director	SSELL◷	224	$27.12	$6.1K	-0.3%	Open the original filing on SEC.gov
Jun 11	Davis Todd C	Director	PBUY	503	$28.73	$14.4K	+0.7%	Open the original filing on SEC.gov
Jun 11	Davis Todd C	Director	PBUY★	35,445	$27.80	$985.5K	+88.9%	Open the original filing on SEC.gov
May 22	Francis Knuettel II	CFO, Treas & Secty	DTOISS◆	42,500	—	—	—	Open the original filing on SEC.gov
May 22	Francis Knuettel II	CFO, Treas & Secty	AGRANT◆	59,500	—	—	—	Open the original filing on SEC.gov
May 22	Francis Knuettel II	CFO, Treas & Secty	SSELL	1,500	$26.84	$40.3K	-11.7%	Open the original filing on SEC.gov
May 22	Francis Knuettel II	CFO, Treas & Secty	DTOISS	13,947	—	—	-41.7%	Open the original filing on SEC.gov
May 14	Friedberg Ezra M	Director	FTAX◷	144	$27.01	$3.9K	-0.2%	Open the original filing on SEC.gov
Apr 2	Pauls Matthew	Director	SSELL◷	371	$21.36	$7.9K	-2.4%	Open the original filing on SEC.gov
Apr 2	Pauls Matthew	Director	SSELL◷	415	$20.52	$8.5K	-2.6%	Open the original filing on SEC.gov
Apr 2	Malamut Richard	Director	SSELL◷	280	$21.36	$6K	-1.0%	Open the original filing on SEC.gov
Apr 2	Malamut Richard	Director	SSELL◷	310	$20.51	$6.4K	-1.1%	Open the original filing on SEC.gov
Apr 2	Greenleaf Peter	Director	SSELL◷	377	$21.36	$8.1K	-1.5%	Open the original filing on SEC.gov
Apr 2	Greenleaf Peter	Director	SSELL◷	420	$20.52	$8.6K	-1.7%	Open the original filing on SEC.gov
Apr 2	Friedberg Ezra M	Director	SSELL◷	265	$21.36	$5.7K	-0.3%	Open the original filing on SEC.gov
Apr 2	Friedberg Ezra M	Director	SSELL◷	293	$20.51	$6K	-0.4%	Open the original filing on SEC.gov
Dec 23, 2025	Einhorn Andrew J.	Director	AGRANT	12,000	—	—	—	Open the original filing on SEC.gov
Dec 17, 2025	Ligand Pharmaceuticals…	Director, 10% Owner	AGRANT◆	—	—	—	—	Open the original filing on SEC.gov
Dec 17, 2025	Ligand Pharmaceuticals…	Director, 10% Owner	DTOISS◆	—	—	—	—	Open the original filing on SEC.gov
Dec 10, 2025	Pauls Matthew	Director	GGIFT	9,542	—	—	-89.9%	Open the original filing on SEC.gov
Nov 25, 2025	Friedberg Ezra M	Director	SSELL	2,000	$28.01	$56K	-6.3%	Open the original filing on SEC.gov
Nov 25, 2025	Friedberg Ezra M	Director	SSELL	1	$28.50	$29	0.0%	Open the original filing on SEC.gov
Nov 25, 2025	Friedberg Ezra M	Director	SSELL	2,000	$28.14	$56.3K	-5.9%	Open the original filing on SEC.gov
Nov 25, 2025	Friedberg Ezra M	Director	SSELL	5,999	$28.00	$168K	-15.0%	Open the original filing on SEC.gov
Nov 13, 2025	Malamut Richard	Director	AGRANT↺	2,454	—	—	+38.0%	Open the original filing on SEC.gov
Nov 6, 2025	Ligand Pharmaceuticals…	Director, 10% Owner	AGRANT◆⚠	—	$9,000,000.00	—	—	Open the original filing on SEC.gov
Oct 2, 2025	Pauls Matthew	Director	MEXER◆	2,123	—	—	—	Open the original filing on SEC.gov
Oct 2, 2025	Pauls Matthew	Director	MEXER	2,123	—	—	+25.0%	Open the original filing on SEC.gov
Jul 2, 2025	Malamut Richard	Director	AGRANT◆	58,230	—	—	—	Open the original filing on SEC.gov
Jul 2, 2025	Malamut Richard	Director	AGRANT◆	19,108	—	—	—	Open the original filing on SEC.gov
Jul 2, 2025	Friedberg Ezra M	Director	AGRANT◆	58,230	—	—	—	Open the original filing on SEC.gov
Jul 2, 2025	Friedberg Ezra M	Director	AGRANT◆	19,108	—	—	—	Open the original filing on SEC.gov
Jul 2, 2025	Davis Todd C	Director	AGRANT◆	58,230	—	—	—	Open the original filing on SEC.gov
Jul 2, 2025	Davis Todd C	Director	AGRANT◆	19,108	—	—	—	Open the original filing on SEC.gov
Jul 2, 2025	Pauls Matthew	Director	MEXER◆	8,493	—	—	—	Open the original filing on SEC.gov
Jul 2, 2025	Pauls Matthew	Director	MEXER	8,493	—	—	—	Open the original filing on SEC.gov
Jul 2, 2025	Plesha Scott M.	CEO and President	AGRANT↺	83,678	—	—	—	Open the original filing on SEC.gov
Jul 2, 2025	Rangarao Sai	Chief Commercial Officer	AGRANT↺	30,518	—	—	—	Open the original filing on SEC.gov
Jul 2, 2025	Pauls Matthew	Director	AGRANT↺	25,478	—	—	—	Open the original filing on SEC.gov
Jul 2, 2025	Malamut Richard	Director	AGRANT↺	19,108	—	—	+214.6%	Open the original filing on SEC.gov
Jul 2, 2025	Greenleaf Peter	Director	AGRANT↺	25,478	—	—	—	Open the original filing on SEC.gov
Jul 2, 2025	Friedberg Ezra M	Director	AGRANT↺	19,108	—	—	+30.1%	Open the original filing on SEC.gov
Jul 2, 2025	Francis Knuettel II	CFO, Treas & Secty	AGRANT↺	33,472	—	—	—	Open the original filing on SEC.gov
Jul 2, 2025	Davis Todd C	Director	AGRANT↺	19,108	—	—	+92.0%	Open the original filing on SEC.gov
Jul 2, 2025	Baxter Richard B	Director	AGRANT↺	19,108	—	—	—	Open the original filing on SEC.gov
Jul 1, 2025	Ligand Pharmaceuticals…	10% Owner	JOTHER◆	31,278.68	—	—	—	Open the original filing on SEC.gov
Jul 1, 2025	Ligand Pharmaceuticals…	10% Owner	CCONV◆	15,000	—	—	—	Open the original filing on SEC.gov
Jul 1, 2025	Ligand Pharmaceuticals…	10% Owner	CCONV	1.5M	$10.00	$15M	—	Open the original filing on SEC.gov
Jul 1, 2025	Friedberg Ezra M	Director	CCONV◆	40,000	—	—	—	Open the original filing on SEC.gov
Jul 1, 2025	Friedberg Ezra M	Director	CCONV◆	40,000	—	—	—	Open the original filing on SEC.gov
Jul 1, 2025	Friedberg Ezra M	Director	PDBUY◆	40,000	—	—	—	Open the original filing on SEC.gov
Jul 1, 2025	Friedberg Ezra M	Director	PDBUY◆	40,000	—	—	—	Open the original filing on SEC.gov
Jul 1, 2025	Friedberg Ezra M	Director	CCONV	40,000	$10.00	$400K	—	Open the original filing on SEC.gov
Jul 1, 2025	Friedberg Ezra M	Director	CCONV	40,000	$10.00	$400K	—	Open the original filing on SEC.gov
Jul 1, 2025	Francis Knuettel II	Chief Financial Officer	CCONV◆	10,000	—	—	—	Open the original filing on SEC.gov
Jul 1, 2025	Francis Knuettel II	Chief Financial Officer	JOTHER◆	10,000	—	—	—	Open the original filing on SEC.gov
Jul 1, 2025	Francis Knuettel II	Chief Financial Officer	CCONV	10,000	$10.00	$100K	—	Open the original filing on SEC.gov
Jul 1, 2025	Davis Todd C	Director, 10% Owner	JOTHER◆	31,278.68	—	—	—	Open the original filing on SEC.gov
Jul 1, 2025	Davis Todd C	Director, 10% Owner	CCONV◆	15,000	—	—	—	Open the original filing on SEC.gov
Jul 1, 2025	Davis Todd C	Director, 10% Owner	CCONV	1.5M	$10.00	$15M	—	Open the original filing on SEC.gov
Apr 11, 2025	Simmons Chia-Lin	Director	AGRANT◆	25,000	—	—	—	Open the original filing on SEC.gov
Apr 11, 2025	Francis Knuettel II	CEO, Pres., CFO, Treas…	AGRANT◆	53,988	—	—	—	Open the original filing on SEC.gov
Nov 13, 2024	Friedberg Ezra M	Director	AGRANT↺	2,454	—	—	+4.0%	Open the original filing on SEC.gov
Nov 13, 2024	Davis Todd C	Director	AGRANT↺	4,961	—	—	+31.4%	Open the original filing on SEC.gov
Jun 14, 2024	Malamut Richard	Director	AGRANT↺	6,450	—	—	—	Open the original filing on SEC.gov
Jun 14, 2024	Friedberg Ezra M	Director	AGRANT↺	6,450	—	—	+11.8%	Open the original filing on SEC.gov
Jun 14, 2024	Davis Todd C	Director	AGRANT↺	12,900	—	—	+442.2%	Open the original filing on SEC.gov

SSELL◷$2.6K

Pauls Matthew · DirectorJul 2

94 sh @ $27.36 · -0.7% own

SSELL◷$18K

Pauls Matthew · DirectorJul 2

692 sh @ $26.00 · -4.6% own

SSELL◷$2.3K

Greenleaf Peter · DirectorJul 2

85 sh @ $27.27 · -0.4% own

SSELL◷$18.5K

Greenleaf Peter · DirectorJul 2

712 sh @ $26.00 · -2.9% own

SSELL◷$656

Friedberg Ezra M · DirectorJul 2

24 sh @ $27.33 · <0.1% own

SSELL◷$13.9K

Friedberg Ezra M · DirectorJul 2

534 sh @ $26.03 · -0.7% own

SSELL◷$1.6K

Friedberg Ezra M · DirectorJun 15

59 sh @ $27.94 · <0.1% own

SSELL◷$6.1K

Friedberg Ezra M · DirectorJun 15

224 sh @ $27.12 · -0.3% own

PBUY$14.4K

Davis Todd C · DirectorJun 11

503 sh @ $28.73 · +0.7% own

PBUY★$985.5K

Davis Todd C · DirectorJun 11

35,445 sh @ $27.80 · +88.9% own

DTOISS◆—

Francis Knuettel II · CFO, Treas & SectyMay 22

42,500 sh

AGRANT◆—

Francis Knuettel II · CFO, Treas & SectyMay 22

59,500 sh

SSELL$40.3K

Francis Knuettel II · CFO, Treas & SectyMay 22

1,500 sh @ $26.84 · -11.7% own

DTOISS—

Francis Knuettel II · CFO, Treas & SectyMay 22

13,947 sh · -41.7% own

FTAX◷$3.9K

Friedberg Ezra M · DirectorMay 14

144 sh @ $27.01 · -0.2% own

SSELL◷$7.9K

Pauls Matthew · DirectorApr 2

371 sh @ $21.36 · -2.4% own

SSELL◷$8.5K

Pauls Matthew · DirectorApr 2

415 sh @ $20.52 · -2.6% own

SSELL◷$6K

Malamut Richard · DirectorApr 2

280 sh @ $21.36 · -1.0% own

SSELL◷$6.4K

Malamut Richard · DirectorApr 2

310 sh @ $20.51 · -1.1% own

SSELL◷$8.1K

Greenleaf Peter · DirectorApr 2

377 sh @ $21.36 · -1.5% own

SSELL◷$8.6K

Greenleaf Peter · DirectorApr 2

420 sh @ $20.52 · -1.7% own

SSELL◷$5.7K

Friedberg Ezra M · DirectorApr 2

265 sh @ $21.36 · -0.3% own

SSELL◷$6K

Friedberg Ezra M · DirectorApr 2

293 sh @ $20.51 · -0.4% own

AGRANT—

Einhorn Andrew J. · DirectorDec 23, 2025

12,000 sh

AGRANT◆—

Ligand Pharmaceuticals… · Director, 10%…Dec 17, 2025

— sh

DTOISS◆—

Ligand Pharmaceuticals… · Director, 10%…Dec 17, 2025

— sh

GGIFT—

Pauls Matthew · DirectorDec 10, 2025

9,542 sh · -89.9% own

SSELL$56K

Friedberg Ezra M · DirectorNov 25, 2025

2,000 sh @ $28.01 · -6.3% own

SSELL$29

Friedberg Ezra M · DirectorNov 25, 2025

1 sh @ $28.50 · 0.0% own

SSELL$56.3K

Friedberg Ezra M · DirectorNov 25, 2025

2,000 sh @ $28.14 · -5.9% own

SSELL$168K

Friedberg Ezra M · DirectorNov 25, 2025

5,999 sh @ $28.00 · -15.0% own

AGRANT↺—

Malamut Richard · DirectorNov 13, 2025

2,454 sh · +38.0% own

AGRANT◆⚠—

Ligand Pharmaceuticals… · Director, 10%…Nov 6, 2025

— sh @ $9,000,000.00

MEXER◆—

Pauls Matthew · DirectorOct 2, 2025

2,123 sh

MEXER—

Pauls Matthew · DirectorOct 2, 2025

2,123 sh · +25.0% own

AGRANT◆—

Malamut Richard · DirectorJul 2, 2025

58,230 sh

AGRANT◆—

Malamut Richard · DirectorJul 2, 2025

19,108 sh

AGRANT◆—

Friedberg Ezra M · DirectorJul 2, 2025

58,230 sh

AGRANT◆—

Friedberg Ezra M · DirectorJul 2, 2025

19,108 sh

AGRANT◆—

Davis Todd C · DirectorJul 2, 2025

58,230 sh

AGRANT◆—

Davis Todd C · DirectorJul 2, 2025

19,108 sh

MEXER◆—

Pauls Matthew · DirectorJul 2, 2025

8,493 sh

MEXER—

Pauls Matthew · DirectorJul 2, 2025

8,493 sh

AGRANT↺—

Plesha Scott M. · CEO and PresidentJul 2, 2025

83,678 sh

AGRANT↺—

Rangarao Sai · Chief Commercial…Jul 2, 2025

30,518 sh

AGRANT↺—

Pauls Matthew · DirectorJul 2, 2025

25,478 sh

AGRANT↺—

Malamut Richard · DirectorJul 2, 2025

19,108 sh · +214.6% own

AGRANT↺—

Greenleaf Peter · DirectorJul 2, 2025

25,478 sh

AGRANT↺—

Friedberg Ezra M · DirectorJul 2, 2025

19,108 sh · +30.1% own

AGRANT↺—

Francis Knuettel II · CFO, Treas & SectyJul 2, 2025

33,472 sh

AGRANT↺—

Davis Todd C · DirectorJul 2, 2025

19,108 sh · +92.0% own

AGRANT↺—

Baxter Richard B · DirectorJul 2, 2025

19,108 sh

JOTHER◆—

Ligand Pharmaceuticals… · 10% OwnerJul 1, 2025

31,278.68 sh

CCONV◆—

Ligand Pharmaceuticals… · 10% OwnerJul 1, 2025

15,000 sh

CCONV$15M

Ligand Pharmaceuticals… · 10% OwnerJul 1, 2025

1.5M sh @ $10.00

CCONV◆—

Friedberg Ezra M · DirectorJul 1, 2025

40,000 sh

CCONV◆—

Friedberg Ezra M · DirectorJul 1, 2025

40,000 sh

PDBUY◆—

Friedberg Ezra M · DirectorJul 1, 2025

40,000 sh

PDBUY◆—

Friedberg Ezra M · DirectorJul 1, 2025

40,000 sh

CCONV$400K

Friedberg Ezra M · DirectorJul 1, 2025

40,000 sh @ $10.00

CCONV$400K

Friedberg Ezra M · DirectorJul 1, 2025

40,000 sh @ $10.00

CCONV◆—

Francis Knuettel II · Chief Financial…Jul 1, 2025

10,000 sh

JOTHER◆—

Francis Knuettel II · Chief Financial…Jul 1, 2025

10,000 sh

CCONV$100K

Francis Knuettel II · Chief Financial…Jul 1, 2025

10,000 sh @ $10.00

JOTHER◆—

Davis Todd C · Director, 10%…Jul 1, 2025

31,278.68 sh

CCONV◆—

Davis Todd C · Director, 10%…Jul 1, 2025

15,000 sh

CCONV$15M

Davis Todd C · Director, 10%…Jul 1, 2025

1.5M sh @ $10.00

AGRANT◆—

Simmons Chia-Lin · DirectorApr 11, 2025

25,000 sh

AGRANT◆—

Francis Knuettel II · CEO, Pres., CFO,…Apr 11, 2025

53,988 sh

AGRANT↺—

Friedberg Ezra M · DirectorNov 13, 2024

2,454 sh · +4.0% own

AGRANT↺—

Davis Todd C · DirectorNov 13, 2024

4,961 sh · +31.4% own

AGRANT↺—

Malamut Richard · DirectorJun 14, 2024

6,450 sh

AGRANT↺—

Friedberg Ezra M · DirectorJun 14, 2024

6,450 sh · +11.8% own

AGRANT↺—

Davis Todd C · DirectorJun 14, 2024

12,900 sh · +442.2% own

Filing record

How quickly insiders here report their trades. Section 16 allows two business days from the transaction.

1 of 25 filings we hold was filed after the two-business-day deadline. The furthest past the deadline was 109 business days late.

Form 4 filings made after the two-business-day deadline, with the transaction date, the filing date and the number of business days between them.
Traded	Filed	Insider	Past deadline	Largest line	Source
Jul 2, 2025	Dec 11, 2025	Pauls MatthewDirector	109days · about 5 months	—	Filing ↗

Pauls MatthewDirector

109days · about 5 months

Traded Jul 2, 2025 · filed Dec 11, 2025Filing ↗

Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings

Insiders at this company

Everyone who has filed a Form 4 for this issuer.

More biotech & pharma companies

Other issuers in the same industry with insider filings on record.

Whole sector →